Sosei Group (OTCMKTS:SOLTF) Share Price Crosses Below Two Hundred Day Moving Average of $16.24

Sosei Group Co. (OTCMKTS:SOLTFGet Free Report) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $16.24 and traded as low as $10.65. Sosei Group shares last traded at $10.65, with a volume of 300 shares.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Jefferies Financial Group downgraded Sosei Group from a “buy” rating to an “underperform” rating in a research report on Tuesday, June 27th. Citigroup downgraded Sosei Group from a “buy” rating to a “sell” rating in a research report on Wednesday, June 28th.

Get Our Latest Stock Report on SOLTF

Sosei Group Price Performance

The company has a fifty day simple moving average of $11.57 and a 200-day simple moving average of $16.24.

Sosei Group Company Profile

(Get Free Report)

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia.

See Also

Receive News & Ratings for Sosei Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sosei Group and related companies with's FREE daily email newsletter.